Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy

This study has been completed.
Information provided by:
AmpliMed Corporation Identifier:
First received: May 17, 2006
Last updated: March 12, 2008
Last verified: March 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2006
  Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)